The Highest Standard in Peptide Research.

Bodytide Wellness Lab
SEXUAL WELLNESS & INTIMACY

PT-141 15MG

Sexual arousal and performance enhancer

PT-141 (Bremelanotide) is an investigational melanocortin agonist formulated to evaluate and restore natural physical desire and arousal pathways.

PT-141 15MG
£128.00

Active Ingredient: 15.00mg per pen

Volume: 3.00ml

For in vitro use only.

Typical research suggests 5 clicks daily, weeks 1-2. Then 10 clicks daily thereafter.

All our Peptide Pens are designed to last a minimum of 30 days.

Taxes included. Shipping calculated at checkout.

Expected Benefits

By combining clinical research with day-to-day wellness support, this protocol offers clear metabolic improvements:

Central Libido Support: Stimulates peak physical desire and spontaneous intimacy thoughts.
Intimacy Longevity: Supports intimate responsiveness for a documented 4 to 8 hours.
Autonomic Arousal: Elevates localized sensitivity and responsiveness.
Vascular Responsiveness: Promotes healthy endothelial function and localized blood flow.
Non-Hormonal Action: Bypasses hormone receptors entirely, working directly through neuro-circuits.

Manufactured and tested to
pharmaceutical standards

EU GMP ISO 9001 ISO 13485 ISO 14644
To maintain the integrity of your protocol, correct storage is essential. Always store your Peptide pen in its protective casing within the refrigerator, strictly between 2°C and 8°C. Ensure the pen is shielded from direct light and never allowed to freeze. When travelling, we recommend utilizing a temperature-controlled travel case.

What is PT-141 15MG?

PT-141 is a centrally-acting peptide designed to evaluate and restore natural physical arousal and desire. Unlike vascular options, it works directly through receptors in the brain to activate the nervous system's natural intimacy triggers.

The Cellular Mechanism

Melanocortin Activation: Binds selectively to MC3R and MC4R receptors to trigger sexual motivation.
Dopamine Regulation: Gently modulates synaptic dopamine, restoring natural anticipation.

Protocol Schedule

Clinical evaluation studies show that a typical research protocol ranges from 250mcg to 500mcg per usage, administered 3-4 hours before sexual activity.

Once targets are achieved, dosage can be reviewed and adjusted according to results.

Possible Side Effects

Arousal Flushing: A brief, warm flush of the face or minor, temporary nausea immediately after administration as receptors adapt.
Nasal Stuffiness: A brief, mild congestion or tickle in the nose that clears quickly.